Company Monitoring Page for Gilead-Sciences

latest headlines for company on cafepharma

Gilead Sciences, Inc Has a Potential Blockbuster Drug for 2014
Motley Fool
Thu, 02/6/14 - 07:43 am
Tags:
Gilead Sciences, hepatitis C, Sovaldi
Gilead to license hepatitis C drug to lower-cost manufacturers in India
Yahoo/Reuters
Wed, 02/5/14 - 06:57 pm
Tags:
hepatitis C, India, Gilead Sciences, Sovaldi
Gilead posts higher profit, strong hepatitis C drug sales
Yahoo/Reuters
Tue, 02/4/14 - 07:01 pm
Tags:
Gilead Sciences, earnings
AbbVie's Challenge to Gilead in Hepatitis C Therapies
Motley Fool
Tue, 02/4/14 - 07:00 pm
Tags:
AbbVie, Gilead Sciences, Sovaldi, hepatitis C, Enanta Pharmaceuticals, ABT-450
Gilead Sciences, Inc. Earnings: Will Sovaldi Send Shares Soaring?
Motley Fool
Tue, 02/4/14 - 08:35 am
Tags:
Gilead Sciences, earnings, Sovaldi
Will Gilead (GILD) Disappoint This Earnings Season?
Motley Fool
Mon, 02/3/14 - 10:43 am
Tags:
Gilead Sciences, earnings
AbbVie Headed to FDA, Clash With Gilead Set
Motley Fool
Sat, 02/1/14 - 10:49 am
Tags:
AbbVie, Gilead Sciences, ABT-450, hepatitis, hepatitis C, Enanta Pharmaceuticals
Mylan Named as Gilead's Exclusive Branded Medicines Business Partner for India
Yahoo
Fri, 01/31/14 - 09:08 am
Tags:
Mylan, generics, Gilead Sciences, India
Idenix Pharma CEO Speaks On Plans for the $107 Million Just Raised
TheStreet.com
Tue, 01/28/14 - 11:17 am
Tags:
Idenix, Pharma CEOs, Gilead Sciences, hepatitis C, Ron Renaud
At $84,000 Gilead Hepatitis C Drug Sets Off Payer Revolt
Bloomberg
Tue, 01/28/14 - 08:37 am
Tags:
Gilead Sciences, hepatitis C, drug pricing, Sovaldi
Liver Drug Race: Intercept Pharma Vs. Rivals
Seeking Alpha
Mon, 01/27/14 - 08:21 am
Tags:
Intercept Pharma, liver disease, OCA, Conatus Pharmaceuticals, Gilead Sciences, Galectin, NASH, non-alcoholic fatty liver disease
High Stakes Intrigue In Hep C: Bristol-Myers Vs. Gilead
Seeking Alpha
Thu, 01/23/14 - 08:23 am
Tags:
hepatitis C, Gilead Sciences, Bristol-Myers Squibb, Sovaldi, declatasvir
Gilead's Sovaldi Hep C Drug Launch Strong
TheStreet.com
Tue, 01/21/14 - 09:35 am
Tags:
Gilead Sciences, Sovaldi, hepatitis C
Forecasting Earnings Growth And Profitability In The Biopharmaceutical Industry
Seeking Alpha
Tue, 01/21/14 - 08:14 am
Tags:
earnings, United Therapeutics, Celgene, Regeneron, Biogen Idec, Acorda Therapeutics, Amgen, Gilead Sciences
Gilead Is Not Done; There Is Potentially 50% More Upside This Year
Seeking Alpha
Sat, 01/18/14 - 11:01 am
Tags:
Gilead Sciences
Standard Review for Gilead's Oncology Candidate
Yahoo/Zacks.com
Tue, 01/14/14 - 11:52 am
Tags:
Gilead Sciences, Idelalisib, refractory indolent non-Hodgkins lymphoma
Bristol-Myers Ties Hepatitis C Success to Gilead’s Pill
Bloomberg
Tue, 01/14/14 - 09:15 am
Tags:
hepatitis C, Gilead Sciences, Bristol-Myers Squibb, Sovaldi, declatasvir
FDA Accepts New Drug Application for Gilead’s Idelalisib for the Treatment of Refractory Indolent Non-Hodgkin’s Lymphoma
Yahoo
Mon, 01/13/14 - 09:41 am
Tags:
FDA, Gilead Sciences, Idelalisib, refractory indolent non-Hodgkins lymphoma
Don't Underestimate Amgen: Part 1
Seeking Alpha
Fri, 01/10/14 - 08:37 am
Tags:
Amgen, Celgene, Gilead Sciences, Biogen Idec
M&A Boom Seen in 2014 as Drug Hunt Spurs Biotech Deals
Bloomberg
Fri, 01/10/14 - 08:25 am
Tags:
M&A, biotech, generics, Merck, Bristol-Myers Squibb, General Electric, Gilead Sciences, Thermo Fisher, Forest Labs, FDA, Acorda Therapeutics, Pfizer, JNJ, Roche, Pharmacyclics

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.